Resources with keywords: pandemic



Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024 (NEW 4/3, Website, Regulatory)
WHO
11 March 2024

The latest update (11 March 2024) includes the following addition and revision:

  • depending on the local risk assessment, less stringent risk control measures for virus isolation and propagation of currently circulating strains;
  • biosafety aspects of waste management;
  • detailed considerations for transportation requirements; and
  • reference to the 4th edition Laboratory biosafety manual for GMPP (good microbiological practice and procedure) and to the Risk assessment monograph for the risk assessment template.
End of the Federal COVID-19 Public Health Emergency (PHE) Declaration (NEW 6/12, Website, Regulatory)
CDC

The federal COVID-19 PHE declaration ended on May 11, 2023.

Correlations and Timeliness of COVID-19 Surveillance Data Sources and Indicators ― United States, October 1, 2020–March 22, 2023 (NEW 6/12, Website, Publication)
CDC/MMWR
12 May 2023

Scobie HM, Panaggio M, Binder AM, et al.
Surveillance data from October 1, 2020–March 22, 2023

COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration ― United States, May 11, 2023 (NEW 6/12, Website, Publication)
CDC/MMWR
12 May 2023

Silk BJ, Scobie HM, Duck WM, et al.
The authors indicate the following: “Changes to the national COVID-19 monitoring strategy and COVID Data Tracker capitalize on marked improvements in multiple surveillance systems.”

Global Influenza Programme: Pandemic influenza preparedness
WHO

The impact of pandemic influenza outbreaks on individuals and societies can be reduced by being well prepared. This means having a comprehensive plan, that has been tested and refined through conducting exercises, engaging the whole of society.

National plans should be flexible enough to respond to outbreaks of various intensity. Communication will be one of the most challenging tasks during an outbreak and it should be planned well in advance.

Community Mitigation Guidelines to Prevent Pandemic Influenza — United States, 2017
CDC/MMWR

Qualls N, Levitt A, Kanade N, et al.

Summary of Influenza Risk Assessment Tool (IRAT) Results
CDC

The Influenza Risk Assessment Tool (IRAT) is an evaluation tool conceived by CDC and further developed with assistance from global animal and human health influenza experts. The IRAT is used to assess the potential pandemic risk posed by influenza A viruses that are not currently circulating in people. Input is provided by U.S. government animal and human health influenza experts.

Biosafety Professionals: A Role in the Pandemic Response Team (NEW 11/2, Document, Publication)
Health Security
16 August 2021
Transition to endemicity: Understanding COVID-19 (NEW 12/5, Website, Publication)
Immunity
12 October 2021

Antia R, Halloran ME

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, coronavirus disease 2019 (COVID-19), has caused a devastating pandemic worldwide. Here, we explain basic concepts underlying the transition from an epidemic to an endemic state, where a pathogen is stably maintained in a population. We discuss how the number of infections and the severity of disease change in the transition from the epidemic to the endemic phase and consider the implications of this transition in the context of COVID-19.

CDC Takes Action to Prepare Against “G4” Swine Flu Viruses in China with Pandemic Potential
CDC
2 July 2020
Go to Top